<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-ijms-21-05145">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Shannon</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>X.-S.</given-names>
   </name>
   <name>
    <surname>Xiang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z.-H.</given-names>
   </name>
   <name>
    <surname>Tebbutt</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Kollmann</surname>
    <given-names>T.R.</given-names>
   </name>
   <name>
    <surname>Fish</surname>
    <given-names>E.N.</given-names>
   </name>
  </person-group>
  <article-title>Interferon-Î±2b Treatment for COVID-19</article-title>
  <source>Front. Immunol.</source>
  <year>2020</year>
  <volume>11</volume>
  <fpage>11</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2020.01061</pub-id>
  <pub-id pub-id-type="pmid">32082309</pub-id>
 </element-citation>
</ref>
